| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| HLA-A*0201 & B2M & PAP (ALDVYNGLL) | PE-Labeled Human HLA-A*02:01&B2M&PAP (ALDVYNGLL) Tetramer Protein | Human | HEK293 | $410.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| SZN-043 | SZN-043; SZN-043双特异性融合蛋白; SZN-043 Bispecific Fusion Protein; SZN-043 (RSPO模拟物) | Phase 1 Clinical | Surrozen Inc | Hepatitis, Alcoholic; Liver Cirrhosis | Details |